Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Theragenics (TGX) on the up and up -- Ignore unavailable to you. Want to Upgrade?

To: Martin Savitska who wrote (802)	4/14/1998 4:33:00 PM
From: Byelow	Read Replies (1) \| Respond to of 1055

Martin: Sorry what's DD (I'm just a simple farm boy)? '96 Annual Report shows 50 million shares authorized. The press release dated 3/16/98 on the 2-1 split said "after the split, THRX will have 29.1 million shares outstanding." Thus, my guess would be to have enough shares authorized in advance for the next split and to protect against hostile takeovers. Note: In early 2/97 THRX put a shareholder rights plan in force to protect against hostile takeovers. That was just before the J&J marketing agreement was signed. In talking with Ron Warren this am I also asked about R&D. I was assured that they are pursuing a strategy with increased spending compared to past but are not prepared to discuss it in public yet. Gosh who knows, maybe we'll get into that lucrative I-125 market that costs so much less and grab a major hunk of the market <smile>! Please remember this is conjecture and an attempt at humor on my part and has no bearing on any discussion I have had with THRX officials or employees! Byelow